A path toward eliminating disease: Cutting-edge genomics research behind the fight against Alzheimer’s, kidney disease, and cancer
Can you imagine a world free of devastating disease? Join The Jackson Laboratory and STAT Brand Studio for a morning with the researchers working to make this vision a reality. Over complimentary breakfast, we'll hear from three Jackson Laboratory scientists who are developing ways to tackle some of our most devastating diseases – Alzheimer’s, kidney disease, and cancer. Harnessing the power of genetics and genomics, they’re aiming to transform the way we treat and even prevent many of the conditions that undermine human health today.
Wednesday, April 24, 2019
8:30 a.m. – 10:30 a.m.
Catherine Kaczorowski, Ph.D.
Associate Professor, Evnin Family Chair in Alzheimer’s Research, The Jackson Laboratory
Identifies early causative events that underlie cognitive deficits associated with ‘normal’ aging and Alzheimer’s disease.
Ron Korstanje, Ph.D., FAHA
Assistant Professor, The Jackson Laboratory
Studies the genetics of kidney function and disease, particularly in the context of aging.
Karolina Palucka, M.D., Ph.D.
Professor and Associate Director, Cancer Immunology, The Jackson Laboratory
Conducts research to understand how vaccines work and to define the immune mechanisms that underlie vaccination, with a focus on cancer immunotherapies.
WHO SHOULD ATTEND
Biotech & pharma executives